Paul Aubert

Laboratoires Paul Aubert was a prominent French pharmaceutical company founded in the early 20th century, specializing in respiratory health and general medicine. The company achieved significant commercial success with its proprietary formulations, most notably Sirop Aubert, which became a staple treatment for cough and respiratory ailments in France for several decades. In 1970, the laboratory was acquired by Synthelabo, a pharmaceutical group that was later integrated into Sanofi following the 1999 merger of Sanofi and Synthelabo. While the company no longer operates as an independent entity, its historical product portfolio remains a recognized part of the French pharmaceutical heritage. Today, its legacy is preserved within the broader historical assets of the Sanofi group.